ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
COVID vaccines

China's vaccine diplomacy spoiled by omicron variant

Sinopharm, Sinovac and CanSino Biologics exports fall 97% on poor protection

A nurse handles vials of Sinopharm's COVID-19 vaccine at a health center in Venezuela in March 2021.   © Reuters

DALIAN, China/TOKYO -- China's exports of domestically produced COVID-19 vaccines have plunged due to weaker protection against the highly transmissible omicron variant compared with U.S. and European products, hindering the country's vaccine diplomacy.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more